Curcumin as a complementary treatment in oncological therapy: a systematic review.

ABSTRACT:

Purpose

Curcumin, the active ingredient in turmeric, is employed by numerous cancer patients to support conventional cancer therapy. This systematic review aims to summarize the existing clinical evidence and to provide an overview of the potential benefits and risks associated with curcumin supplementation.

Methods

In January 2024, we conducted a systematic search of five electronic databases (Embase, Cochrane, PsycInfo, CINAHL, and Medline) using a complex search strategy. We included randomized controlled trials on the use, effectiveness, and potential harm of additional curcumin therapy in adult patients under cancer treatment. The risk of bias was assessed using Cochrane revised Risk of Bias Tool 2.0.

Results

This systematic review included 34 randomized controll

SUBMITTER: Gutsche LC 

PROVIDER: S-EPMC11695395 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature